4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-16-127493
CIK 0001660719operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 9:45 PM ET
Size
7.0 KB
Accession
0001104659-16-127493
Insider Transaction Report
Form 4
thrasher francis martin
Director
Transactions
- Exercise/Conversion
Stock Options (right to buy)
2016-06-13−4,365→ 0 totalExercise: $2.82Exp: 2016-06-22→ Common Shares, without par value (4,365 underlying) - Exercise/Conversion
Common Shares, without par value
2016-06-13$2.82/sh+4,365$12,309→ 277,178 total
Footnotes (2)
- [F1]Price is presented in Canadian dollars.
- [F2]The option was exercisable as of the Reporting Person's previous filing on Form 3, dated as of February 8, 2016.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 9:45 PM ET
- Size
- 7.0 KB